CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Glycemic Efficacy and Metabolic Consequences of an Empagliflozin Add-on versus Conventional Dose-Increasing Strategy in Patients with Type 2 Diabetes Inadequately Controlled by Metformin and Sulfonylurea
Yujin Shin, Ji Hye Moon, Ho Jun Chin, Ele Ferrannini, Soo Lim
Endocrinol Metab. 2020;35(2):329-338.   Published online June 24, 2020
DOI: https://doi.org/10.3803/EnM.2020.35.2.329

Excel Download

Glycemic Efficacy and Metabolic Consequences of an Empagliflozin Add-on versus Conventional Dose-Increasing Strategy in Patients with Type 2 Diabetes Inadequately Controlled by Metformin and Sulfonylurea
Endocrinology and Metabolism. 2020;35(2):329-338   Crossref logo
Link1 Link2 Link3

PO184 COMPARISON OF VILDAGLIPTIN AS AN ADD-ON THERAPY AND SULFONYLUREA DOSE-INCREASING THERAPY IN PATIENTS WITH INADEQUATELY CONTROLLED TYPE 2 DIABETES USING METFORMIN AND SULFONYLUREA
Diabetes Research and Clinical Practice. 2014;106:S141   Crossref logo
Link1 Link2

Comparison of vildagliptin as an add-on therapy and sulfonylurea dose-increasing therapy in patients with inadequately controlled type 2 diabetes using metformin and sulfonylurea (VISUAL study): A randomized trial
Diabetes Research and Clinical Practice. 2015;109(1):141-148   Crossref logo
Link1 Link2

Improved Glycemic Control with Insulin Glargine Versus Pioglitazone as Add-On Therapy to Sulfonylurea or Metformin in Patients with Uncontrolled Type 2 Diabetes Mellitus
Endocrine Practice. 2010;16(4):588-599   Crossref logo
Link1 Link2 Link3

Efficacy and safety of empagliflozin twice daily versus once daily in patients with type 2 diabetes inadequately controlled on metformin: a 16-week, randomized, placebo-controlled trial
Diabetes, Obesity and Metabolism. 2015;17(7):699-702   Crossref logo
Link1 Link2

Efficacy and safety of acarbose add-on therapy in the treatment of overweight patients with Type 2 diabetes inadequately controlled with metformin: a double-blind, placebo-controlled study
Diabetes Research and Clinical Practice. 2000;50(1):49-56   Crossref logo
Link1 Link2

PO173 EFFICACY AND SAFETY OF ANAGLIPTIN COMPARED WITH SITAGLIPTIN AS AN ADD-ON FOR PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED WITH METFORMIN MONOTHERAPY
Diabetes Research and Clinical Practice. 2014;106:S135-S136   Crossref logo
Link1 Link2

Durability of glycaemic efficacy over 2 years with dapagliflozin versus glipizide as add-on therapies in patients whose type 2 diabetes mellitus is inadequately controlled with metformin
Diabetes, Obesity and Metabolism. 2014;16(11):1111-1120   Crossref logo
Link1 Link2

Efficacy and safety of ipragliflozin in patients with type 2 diabetes inadequately controlled on metformin: a dose-finding study
Diabetes, Obesity and Metabolism. 2012;15(5):403-409   Crossref logo
Link1 Link2

Comparative efficacy of exenatide versus insulin glargine on glycemic control in type 2 diabetes mellitus patients inadequately treated with metformin monotherapy
Advances in Medical Sciences. 2013;58(1):38-43   Crossref logo
Link1 Link2